Laura C. Cooper

Statistics

Publications

Citations

149

H-Index

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Laura C. Cooper is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, molecular pharmacology, and ligand binding.

Publications per year

2001–2009

Publications

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura C. Cooper, Gary G. Chicchi, Kevin Dinnell et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Novel Orally Bioavailable γ-Secretase Inhibitors with Excellent in Vivo Activity

Linda E. Keown, Ian Collins, Laura C. Cooper et al. · Journal of Medicinal Chemistry · 2009 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

2,5-Disubstituted pyridines: The discovery of a novel series of 5-HT2A ligands

Kevin J. Wilson, Monique B. van Niel, Laura C. Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 25 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +14

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II

Laura C. Cooper, Emma Carlson, José L. Castro et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists I

Jason Elliott, José L. Castro, Gary G. Chicchi et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 10 citations

Medicine, Medicinal Chemistry, Pharmacology +7

1–5 of 5